Reliability of receptor assessment on core needle biopsy in breast cancer patients
2012 · Tumor Biology · 23 citations
https://doi.org/10.1007/s13277-012-0635-5
F
F. Van den Berkmortel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
515
Citations
8
h-index
8
i10-index
F. Van den Berkmortel is an academic researcher from Zuyderland Medisch Centrum. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Melanoma and MAPK Pathways & Breast Cancer Treatment Studies. The author has an h-index of 8, co-authored 41 publications.
ORCID: 0000-0002-2400-0692Papers by this author
worksReal-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium
2017 · European Journal of Cancer · 20 citations
https://doi.org/10.1016/j.ejca.2017.01.027
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma
2025 · Medical Decision Making · 1 citations
https://doi.org/10.1177/0272989x251319338
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis
2025 · Journal of Neuro-Oncology · 1 citations
https://doi.org/10.1007/s11060-025-05299-0
Receptor Discordance During the Treatment Course of Patients With Metastatic Breast Cancer: Results From the SONABRE Registry
2025 · Clinical Breast Cancer · 0 citations
https://doi.org/10.1016/j.clbc.2025.07.020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat